Insmed Corp (INSM) Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati

Insmed Corp (INSM) korporativ emblemasi va logotipi

Insmed Incorporated (INSM) molekulalarni tezkor tanlash uchun sun'iy intellekt laboratoriyalaridan foydalangan holda, o'pka kasalliklari bilan og'rigan bemorlar uchun inqilobiy terapiyalarni tijoratlashtirmoqda. GURU.Markets platformasi grafigidagi narx ko'rsatkichi aktivning narx harakatini namoyish etadi, bunda yakka uzoq muddatli qarzdorlikning kapitalga nisbati 0.94 ga tengdir. Ilmiy hamjamiyatdagi yuqori brend obro'si og'ir patologiyalar uchun noyob davolash usullariga shifokorlarning shubhasiz ishonchini ta'minlaydi.

INSM Insmed Inc: Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 30.10.2026 oraligʻida
Insmed Incorporated ishlab chiqargan mahsulot

Uzoq muddatli qarzdorlikning kapitalga nisbati kapital tuzilmasining qarz resurslariga bog'liqligini o'lchaydi, bu esa R&D operatsion xarajatlariga sezgir hisoblanadi. Biznes modelining kamyob dorilarga bo'lgan noelastik talab bilan himoyalangan Insmed Incorporated (INSM) uchun ushbu muvozanat bankrotlik xavfisiz ishlanmalarni kengaytirish qobiliyatini belgilaydi, bu tendentsiya uzoq muddatli qarzdorlikning kapitalga nisbatidagi narx harakati orqali aks etadi.

Muhim raqobatchilar

Vertex Pharmaceuticals Incorporated (VRTX) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Alnylam Inc. (ALNY)|UTHR: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BMRN (BioMarin Pharmaceutical)|bridgebio.com (BBIO) - Uzoq muddatli majburiyatlarning kapitalga nisbati|BGM Group Corp - Uzoq muddatli qarzning kapitalga nisbati|Cogent Biosciences Inc (COGT) - Uzoq muddatli qarzning o'z kapitaliga nisbati|XERS: Uzoq muddatli qarzning kapitalga nisbati|KROS - Uzoq muddatli qarzdorlikning kapitalga nisbati|ARCT (Arcturus Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati etonpharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Kamada (KMDA)|Uzoq muddatli qarzning o'z kapitaliga nisbati FULC (Fulcrum Therapeutics Inc)|Uzoq muddatli qarzning kapitalga nisbati ABEO (Abeona Therapeutics Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati Mereo BioPharma Group (MREO)|PLX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati PLRX|APLT: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Rein Therapeutics Inc. (RNTX)|GELS (Gelteq Ltd) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi AYTU (Aytu Therapeutics)|Uzoq muddatli qarzning o'z kapitaliga nisbati CMMB (Chemomab Therapeutics)|SRXH (srxhealth.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Polyrizon PLRZ|AEZS (Aeterna Zentaris Inc) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|CTD Holdings - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti INZY (Inozyme Pharma, Inc.)|RPHM: Uzoq muddatli qarzning kapitalga nisbati|cosciensbio.com (CSCI) - Uzoq muddatli qarzning kapitalga nisbati